Navigation Links
Susquehanna Growth Equity Acquires MediMedia Information Technologies, LLC
Date:4/18/2011

BALA CYNWYD, Pa., April 18, 2011 /PRNewswire/ -- Susquehanna Growth Equity, LLC (SGE) today announced that it has acquired MediMedia Information Technologies, LLC (MMIT), a provider of managed care information for the healthcare industry.

MMIT engages in the collection, consolidation, and interpretation of pharmaceutical and healthcare information from health plans to meet the needs of healthcare decision makers in managed markets. In addition, it offers data collection, analysis, and related services to the managed care marketplace.

"MMIT is a leader in the area of formulary information management, a position we intend to leverage with a plan of enhancing the company's platform through the addition of adjacent data sets and front-end analytic capabilities," said Scott Feldman of Susquehanna Growth Equity. "In an environment of increasing regulatory reform and cost consciousness, pharmaceutical companies, insurance plans, and providers continue to demand more comprehensive sources of managed care information. MMIT has been the leader in this space for the past decade and is extremely well-positioned to meet the growing needs of this marketplace. Mr. Feldman along with Vincenzo La Ruffa and Amir Goldman will be joining the company's board of directors."

MMIT has been led by a dedicated team of healthcare professionals for the last decade. All employees will remain with the company. Martin Caron will continue to serve as President and Chief Executive Officer. As part of the transaction, Ronald Berg has joined as Chief Operating Officer and Chief Financial Officer. Mr. Berg previously served in senior executive roles at RadPharm, Idealab, Deja.com, and Infonautics. Thomas Gardner has also joined the team as Chairman of the Board. Mr. Gardner has been an executive, investor, and advisor in the healthcare industry since 1970, and has served in senior roles at Johnson & Johnson, the Dun & Bradstreet Corporation, and IMS Health.

"SGE's investment in MMIT will accelerate our development efforts, allowing us to quickly meet customer needs in today's fast-paced business environment," said Martin Caron of MMIT. "We are all looking forward to the considerable insight and experience that Ron and Tom bring to the company and are excited to work with SGE to continue delivering innovative solutions to our customer segments."

About MMIT

MMIT provides plan-specific and managed care formulary information to pharmaceutical, health insurance, and electronic prescribing companies. The company's solutions are all built around a central formulary database integrating data from managed care organizations, pharmacy benefit managers, health maintenance organizations, preferred provider organizations, state Medicaid plans, over 1000 Medicare Part D plans, and self-insured employer plans.

The company was founded in 1994 and is based in Yardley, Pennsylvania. For additional information please visit www.mminfotech.com.

About Susquehanna Growth Equity, LLC

Susquehanna Growth Equity, LLC (SGE) is a private equity group investing in growth capital and buyout opportunities in information services, software, and financial technology. SGE's team of dedicated investment professionals brings a unique set of experience combining venture investing with operational expertise. For additional information please visit www.sgep.com.

SGE is an affiliate of Susquehanna International Group, LLP (SIG), a world-leading, technology empowered financial trading firm specializing in making markets and providing liquidity. SIG includes affiliated entities specializing in institutional brokerage, research, private equity, and venture capital. SIG employs approximately 1,500 individuals located in North America, Europe, Asia, and Australia. For additional information please visit www.sig.com.


'/>"/>
SOURCE Susquehanna Growth Equity, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Susquehanna Financial Group Hires Gary Nachman as Senior Analyst to Cover the Specialty Pharmaceuticals Sector
2. HealthWarehouse.com Reports 278% Year-Over-Year Prescription Growth
3. According to the Journal of Advanced Nursing, RyMed Technologies InVision-Plus® Excels at Minimizing Bacterial Growth In Vitro
4. MEDomics Announces a Growth Capital Investment from SpaGus Ventures LLC and Gary Augusta Joins MEDomics as Chief Operating Officer
5. Reportlinker Adds Butadiene Market In Americas To 2020 - Recovery In End Use Markets Providing Positive Demand Growth In The Region
6. Fueling Interventional Radiology Growth: SIR Foundation Announces Navilyst Medical Pledge
7. Generex Provides Further Information for March 30 Press Conference & Investor Call to Discuss Managements Strategic Development Plan for Future Growth
8. NephRx Corp. Awarded U.S. Patent for Use of Novel Growth Factor Peptide NX002 in Inflammatory Bowel Disease
9. Generex Schedules Press Conference & Investor Call for March 30th to Discuss Managements Strategic Development Plan for Future Growth
10. Vystar® Corporation Secures a $3M Credit Facility to Fund Growth
11. OncoSec Medical to Present at ROTH 23rd Annual Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... NEW YORK , April 19, 2017 Cardiology ... during the projected period The Cardiology Devices segment ... more than US$ 15 Mn in 2018 over 2017. By ... reach a market valuation close to US$ 700 Mn, expanding ... Cardiology Devices segment dominated the Asia Pacific ...
(Date:4/19/2017)... , Tenn. and DALLAS , April 19, ... Inc., announced that the first patients in ... EndoStim device in the Lower Esophageal Sphincter Stimulation for ... minimally-invasive implantable device designed to provide long-term reflux control ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... N.J. , April 19, 2017  Novartis ... by the National Heart, Lung, and Blood Institute ... demonstrating that 58% of patients with treatment-naïve severe ... months when treated with eltrombopag at the initiation ... . The study evaluated three sequential treatment groups, ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab Physical ... be the preferred physical therapy provider for Derby City CrossFit, effective immediately. , ... CrossFit as quickly and effectively as possible, ProRehab’s sports physical therapists will work ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent report from ... performance for the 2015-16 school year across Wisconsin’s public schools, charter schools, and ... important patterns in student test score performance, the report’s limited analyses fail to ...
(Date:4/25/2017)... ... April 25, 2017 , ... As ... contracted partners to help with process innovation in drug formulation and manufacturing. ... along with state-of-the-art analytical equipment in support of their development and manufacturing goals. ...
(Date:4/25/2017)... ... 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest quality of spine ... focus on preventative care with all my patients to alleviate possible future issues. I am ... to contact my office and my trained staff will assist you in any way possible.” ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
Breaking Medicine News(10 mins):